Consilient Health
Amanda Paxon has a wealth of experience in the healthcare industry, with a background in consulting, sales, and management. Amanda currently serves as the Country Manager for Prescription Medicine at Consilient Health Ltd. Prior to this, Amanda worked as a Principal Consultant at GalbraithWight, focusing on brand planning and market access. Amanda also served as a Director at Boehringer Ingelheim, leading sales teams and successfully launching various brands. Additionally, Amanda has experience as a Non Executive Director at Datapharm Communications Ltd. Amanda has completed various education programs in digital marketing, management development, and global leadership.
This person is not in any teams
This person is not in any offices
Consilient Health
Consilient Health is a pharmaceutical company with a rich heritage of commercialising medicines in areas including women’s health, urology and endocrinology. Established in 2005, Consilient Health is headquartered in Ireland with offices in the UK and Sweden (for the Nordic region) We have formed strong partnerships in Benelux and Spain and continue to expand our geographic footprint in Europe. As an independent, privately-held and profitable business with a strong balance sheet, we can make decisions quickly and are able to invest in long-term collaborations and partnerships to expand our portfolio of products and to support our partners’ objectives. Our goal is to address patients’ and healthcare professionals’ unmet needs with medicines that are differentiated and we are actively seeking to in-license late stage developments or marketed products. We do not undertake research and development and are not a manufacturer. Consilient Health deliver everything from regulatory affairs through to market access, supply chain, distribution, medical affairs, marketing and sales all underpinned by quality and compliance. Our focus is on driving value in our partners’ brands, maximizing their commercial potential, enabling them to expand their geographical footprint and providing access for patients. For more information please visit www.consilienthealth.com CORP-CH-204(2) Date of preparation July 2022